Results for tag: "Natpara"

Natpara is a drug used to treat endocrine and metabolic disorders. It is a recombinant human parathyroid hormone (PTH) analog that helps to regulate calcium and phosphorus levels in the body. Natpara is used to treat hypoparathyroidism, a condition in which the body does not produce enough parathyroid hormone. It is also used to treat osteoporosis in postmenopausal women. Natpara is administered as a subcutaneous injection and is available in both brand-name and generic forms. The Natpara market is highly competitive, with several major players. These include Shire, Novartis, Eli Lilly, and Amgen. These companies are engaged in research and development of new drugs and formulations to meet the needs of patients with endocrine and metabolic disorders. They are also involved in marketing and distribution of Natpara and other drugs in this therapeutic area. Show Less Read more